首頁 > 市場調查報告書 > 製藥

DDS

市場調查報告書

商品編碼

1542405

全球靜脈解決方案市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Intravenous Solutions Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 222 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球靜脈注射解決方案市場需求預計將從 2023 年的 179.9 億美元達到近 354.9 億美元的市場規模，2024-2032 年研究期間複合年成長率為 7.84%。

靜脈 (IV) 溶液是直接注射到患者靜脈的無菌液體，用於輸送藥物、營養物質或液體以達到治療目的。對於無法口服液體或需要立即吸收藥物的患者來說，這些解決方案在醫療環境中至關重要。靜脈注射液通常含有水、電解質（鈉、鉀和氯化物）的均衡組合，有時還含有葡萄糖或藥物等其他物質。它們在維持水合和電解質平衡以及支持接受手術、疾病復健或管理慢性病的患者的重要功能方面發揮著不可或缺的作用。靜脈注射液有多種類型和成分可供選擇，可根據特定的醫療需求和治療要求進行客製化，確保精確的輸送和治療效果。

市場動態

慢性病、手術和醫療緊急情況的日益普及需要可靠的靜脈解決方案來補充液體、藥物輸送和營養支持。醫療技術的進步，例如改進的輸液幫浦和導管設計，提高了靜脈注射的安全性和效率，有助於改善病患的治療效果並減少住院時間。人口老化和複雜疾病發病率上升等人口趨勢推動了市場成長。門診護理和家庭醫療保健環境的擴大進一步推動了對靜脈注射解決方案的需求，患者需要方便、攜帶式的輸液選擇來進行持續治療管理。

靜脈注射治療的技術創新，包括智慧靜脈注射幫浦和整合電子病歷，提高了治療精確度和病患監測，促進了醫療機構的採用。此外，旨在提高病患安全和品質標準的監管措施為合規靜脈注射解決方案製造商創造了擴大市場佔有率和創新新產品的機會。製藥公司、醫療器材製造商和醫療保健提供者之間的策略合作促進了產品開發和分銷，增強了全球市場競爭力和可擴展性。然而，醫療保健系統中對產品核准和定價動態的嚴格監管要求阻礙了市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球靜脈解決方案市場的每個細分市場進行了包容性評估。靜脈注射解決方案產業的成長和趨勢為本研究提供了整體方法。

市場區隔

靜脈解決方案市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按類型

全腸外營養
周邊腸外營養

按成分分類

碳水化合物
維生素和礦物質
單劑量胺基酸
腸外脂質乳劑
其他成分

按年齡段

兒科
成人
老年科

按申請

營養支持
輸血
液體和電解質平衡
其他應用

按最終用戶

醫院和診所
門診手術中心
居家照護環境

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲靜脈解決方案市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。靜脈注射解決方案市場的主要參與者包括Ajinomoto Co Inc.、Amanta Healthcare、Axa Parenterals Ltd、B.Braun Melsungen AG、Baxter International Inc.、Fresenius Kabi USA LLC、Grifols SA、ICU Medical Inc、JW Life Science、Otsuka Pharmaceutical有限公司、輝瑞公司。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按類型分類的市場吸引力分析
- 按構成進行的市場吸引力分析
- 按年齡層別分類的市場吸引力分析
- 市場吸引力分析：依應用分類
- 最終用戶的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球靜脈注射解決方案市場分析：按類型

按類型概述
按類型分析歷史和預測數據
全腸外營養
周邊腸外營養

第 6 章：全球靜脈注射解決方案市場分析：依構成

按成分概述
按成分分析歷史和預測數據
碳水化合物
維生素和礦物質
單劑量胺基酸
腸外脂質乳劑
其他成分

第 7 章：全球靜脈注射解決方案市場分析：按年齡層

按年齡層別概述
按年齡層別進行的歷史和預測資料分析
兒科
成人
老年科

第 8 章：全球靜脈注射解決方案市場分析：按應用分類

概述：按應用
歷史與預測資料分析：按應用分類
營養支持
輸血
液體和電解質平衡
其他應用

第 9 章：全球靜脈注射解決方案市場分析：按最終用戶分類

最終用戶概述
最終用戶的歷史和預測數據分析
醫院和診所
門診手術中心
居家照護環境

第 10 章：全球靜脈注射解決方案市場分析：按地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 11 章：靜脈注射液公司的競爭格局

靜脈注射解決方案市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 12 章：公司簡介

頂級公司市佔率分析
市場集中度
Ajinomoto Co Inc.

公司概況
公司收入
產品
最新動態

Amanta Healthcare

公司概況
公司收入
產品
最新動態

Axa Parenterals Ltd

公司概況
公司收入
產品
最新動態

B.Braun Melsungen AG

公司概況
公司收入
產品
最新動態

Baxter International Inc.

公司概況
公司收入
產品
最新動態

Fresenius Kabi USA LLC

公司概況
公司收入
產品
最新動態

Grifols SA

公司概況
公司收入
產品
最新動態

ICU Medical Inc

公司概況
公司收入
產品
最新動態

JW Life Science

公司概況
公司收入
產品
最新動態

Otsuka Pharmaceutical Co. Ltd

公司概況
公司收入
產品
最新動態

Pfizer Inc

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11219483

The global demand for Intravenous Solutions Market is presumed to reach the market size of nearly USD 35.49 Billion by 2032 from USD 17.99 Billion in 2023 with a CAGR of 7.84% under the study period 2024-2032.

Intravenous (IV) solutions are sterile fluids administered directly into a patient's veins to deliver medications, nutrients, or fluids for therapeutic purposes. These solutions are essential in medical settings for patients who cannot consume liquids orally or require immediate absorption of medications. Intravenous solutions typically contain a balanced combination of water, electrolytes (sodium, potassium, and chloride), and sometimes additional substances like glucose or medications. They play an integral role in maintaining hydration & electrolyte balance and supporting vital functions in patients undergoing surgery, recovering from illnesses, or managing chronic conditions. IV solutions are available in various types and compositions, which are customized to meet specific medical needs and treatment requirements, ensuring precise delivery and therapeutic efficacy.

MARKET DYNAMICS

The increasing prevalence of chronic diseases, surgeries, and medical emergencies necessitates reliable intravenous solutions for fluid replacement, medication delivery, and nutritional support. Advances in medical technology, such as improved infusion pumps and catheter designs, enhance the safety and efficiency of IV administration, contributing to better patient outcomes and reduced hospital stays. Demographic trends such as aging populations and the rising incidence of complex diseases drive market growth. The demand for intravenous solutions is further bolstered by the expansion of outpatient care and home healthcare settings, where patients require convenient and portable infusion options for continuous therapy management.

Technological innovations in IV therapy, including smart IV pumps and integrated electronic medical records, improve treatment precision and patient monitoring, promoting adoption across healthcare facilities. Moreover, regulatory initiatives to enhance patient safety and quality standards create opportunities for compliant intravenous solutions manufacturers to expand their market presence and innovate new products. Strategic collaborations among pharmaceutical companies, medical device manufacturers, and healthcare providers facilitate product development and distribution, enhancing market competitiveness and scalability globally. However, stringent regulatory requirements for product approval and pricing dynamics in healthcare systems hampers market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Intravenous Solutions. The growth and trends of Intravenous Solutions industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Intravenous Solutions market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Total Parenteral Nutrition
Peripheral Parenteral Nutrition

By Composition

Carbohydrates
Vitamins & Minerals
Single-Dose Amino Acids
Parenteral Lipid Emulsion
Other Compositions

By Age Group

Pediatric
Adult
Geriatric

By Application

Nutritional Support
Blood Transfusion
Fluid & Electrolyte Balance
Other Applications

By End-User

Hospitals And Clinics
Ambulatory Surgery Centers
Home Care Setting

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Intravenous Solutions market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Intravenous Solutions market include Ajinomoto Co Inc., Amanta Healthcare, Axa Parenterals Ltd, B.Braun Melsungen AG, Baxter International Inc., Fresenius Kabi USA LLC, Grifols S.A., ICU Medical Inc, JW Life Science, Otsuka Pharmaceutical Co. Ltd, Pfizer Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. INTRAVENOUS SOLUTIONS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Composition
- 3.7.3 Market Attractiveness Analysis By Age Group
- 3.7.4 Market Attractiveness Analysis By Application
- 3.7.5 Market Attractiveness Analysis By End-User
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Total Parenteral Nutrition Historic and Forecast Sales By Regions
5.4. Peripheral Parenteral Nutrition Historic and Forecast Sales By Regions

6. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY COMPOSITION

6.1. Overview By Composition
6.2. Historical and Forecast Data Analysis By Composition
6.3. Carbohydrates Historic and Forecast Sales By Regions
6.4. Vitamins & Minerals Historic and Forecast Sales By Regions
6.5. Single-Dose Amino Acids Historic and Forecast Sales By Regions
6.6. Parenteral Lipid Emulsion Historic and Forecast Sales By Regions
6.7. Other Compositions Historic and Forecast Sales By Regions

7. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY AGE GROUP

7.1. Overview By Age Group
7.2. Historical and Forecast Data Analysis By Age Group
7.3. Pediatric Historic and Forecast Sales By Regions
7.4. Adult Historic and Forecast Sales By Regions
7.5. Geriatric Historic and Forecast Sales By Regions

8. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY APPLICATION

8.1. Overview By Application
8.2. Historical and Forecast Data Analysis By Application
8.3. Nutritional Support Historic and Forecast Sales By Regions
8.4. Blood Transfusion Historic and Forecast Sales By Regions
8.5. Fluid & Electrolyte Balance Historic and Forecast Sales By Regions
8.6. Other Applications Historic and Forecast Sales By Regions

9. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY END-USER

9.1. Overview By End-User
9.2. Historical and Forecast Data Analysis By End-User
9.3. Hospitals And Clinics Historic and Forecast Sales By Regions
9.4. Ambulatory Surgery Centers Historic and Forecast Sales By Regions
9.5. Home Care Setting Historic and Forecast Sales By Regions

10. GLOBAL INTRAVENOUS SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE INTRAVENOUS SOLUTIONS COMPANIES

11.1. Intravenous Solutions Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF INTRAVENOUS SOLUTIONS INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Ajinomoto Co Inc.
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Amanta Healthcare
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Axa Parenterals Ltd
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. B.Braun Melsungen AG
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. Baxter International Inc.
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. Fresenius Kabi USA LLC
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Grifols S.A.
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. ICU Medical Inc
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. JW Life Science
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. Otsuka Pharmaceutical Co. Ltd
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments
12.13. Pfizer Inc
- 12.13.1 Company Overview
- 12.13.2 Company Revenue
- 12.13.3 Products
- 12.13.4 Recent Developments